AlphaYouJA
Insider selling
Jonathan Allan sold $92K of Stoke Therapeutics, Inc. (STOK) stock
Jonathan Allan, General Counsel & Corp Sec of Stoke Therapeutics, Inc. (STOK), sold 2,861 shares of STOK stock worth $92K, per an SEC Form 4 filed Aug 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 14, 2026, 5 days before it was made public.
STOK has moved -10.3% since the trade date, from $31.27 to $28.05 (Sep 21, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 19, 2026
- Filing delay
- 5 days
- Price since
- -10.3%
- Role
- General Counsel & Corp Sec
- Source
- SEC Form 4
More STOK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.